Live respiratory tract infection updates

Live respiratory tract infection news coverage of developments with the latest updates. Stay on top of latest respiratory tract infection news stories and find out what just happened, what is going on with respiratory tract infection. The latest real-time news updates and headlines on respiratory tract infection
Inhaled antibiotics could help reduce antimicrobial resistance
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Combination nasal spray Ryaltris now approved for Australian children aged six years and older with hay fever or other year-round
Study to test anti-viral effects of Lactoferrin
Covid Increases risk of type 2 diabetes
Scientists find direct links between deforestation and reduced dietary quality
Could Viruses, Olfactory ‘Railroad Track’ Unlock Alzheimer’s Puzzle?
Nirsevimab significantly protected infants against RSV disease in Phase III MELODY trial
Bacteria in nose may increase risk of Alzheimer’s disease – study
Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants
Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus
Research suggests two paths toward ‘super immunity’ to Covid
Dramatic fall in hospital admissions for child infections since start of Covid pandemic
Dramatic fall in hospital admissions for child infections during first year of Covid pandemic
Rising health risks for children across Afghanistan as disruption to health and nutrition services continues and winter sets in
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Tezspire approved in US for severe asthma
U.S. FDA Approves Pfizer’s XELJANZ for Treatment of Active Ankylosing Spondylitis
Largest annual decrease in antibiotic use in community in two decades
Parent-collected nose swabs are as good as nurse-collected nose swabs at detecting respiratory infections in kids
Zinc shown to prevent symptoms and shorten duration of common cold and flu-like illnesses
Zinc might help to stave off respiratory infection symptoms and cut illness duration
Research reveals environmental and social factors contribute to higher rates of pneumonia in kids
Lactoferrin supplements could aid in recovery of COVID19
Real-world data shines light on impact of Covid on psoriasis patients
Largest trial of antibiotic amoxicillin for treating chest infections in children finds little effect
Saphnelo approved in Japan for systemic lupus erythematosus
Astellas’ and Pfizer’s XTANDI Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer
Scientists discover association between early lower respiratory tract infections and development of obstructive sleep apnea
XELJANZ Receives Marketing Authorization in European Union for Treatment of Active Polyarticular Juvenile Idiopathic Arthritis
36 per cent drop in antibiotic prescribing following Covid restrictions
Antibiotic resistance is global health challenge that can’t be ignored
Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata
Children’s Hospital of Philadelphia researchers identify approach for potential nontypeable haemophilus influenzae vaccine
Saphnelo approved in US for moderate to severe systemic lupus erythematosus
Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ Filings
Tezepelumab regulatory submission accepted and granted FDA Priority Review
Refugee health challenges remain high amid COVID-19
Nirsevimab MEDLEY Phase II/III trial demonstrated favourable safety and tolerability profile in infants
In many cases, multiple sclerosis starts long before diagnosis
Researchers identify gene responsible for increased risk of infantile fragility
Dstl research behind trial of new blood test to predict sepsis
Very high use of antibiotics in COVID-19 treatment could be reduced
Anifrolumab showed benefit across different measures of skin and joint disease activity
WFP ramps up support to Yemen’s famine risk areas
Reimagining Global Research in a Pandemic
Global Therapeutics fined $119,880 for alleged unlawful advertising of complementary medicines
Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV lower respiratory tract infections